Marine microalgae are produced with a minimal carbon footprint.
animal-like protein, coming from a plant, with a proven immunomodulatory effect.”
Marine microalgae in biofilm a niche market Vasseur and his team are working hard to prove the worth of their product, but Vasseur emphasises “we offer our product in Europe, but this is still a niche market, and we are produc- ing at a fraction of our potential capacity. We are evaluating possibilities further down the road for working with industrial partners,” he says. Like others, Inalve too was faced with the challenges of Covid-19: “We modified our daily work and work plan, which was very strange as we are a very agile company. When you are an international group, switching di- rections is a tough challenge; it takes a lot of effort to adapt to the new situation,” Vasseur says. The company did, however, succeed in achieving its overarching goal for 2020: “our goal was to set up a pilot farm in Nice, in the south of France − a world premiere which is now up and running.”
Covid did not alter the company’s goal Vasseur concludes by saying that even though Covid-19 did impact his company, it did not change the company’s goal. “By 2022, we will enter the demonstration phase to show the
world that we can produce at the volume and level of sustain- ability that we claim to at our price point. Beyond Europe, we see our next potential in North America and are raising funds to enter the market there.”
Marine microalgae provide an animal-like protein, derived from a plant, with a proven immunomodulatory effect.
▶ ALL ABOUT FEED | Volume 29, No. 4, 2021 25
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36
